Paragraph 13A Accessing summary care recordsF1
United Kingdom
An LPS chemist (C) must have access to summary care records at C’s scheme premises, and must ensure that the access that C has to summary care records at those premises is constant and reliable during the hours when the scheme premises are open to the public, in so far as that is within the control of C.
C must access the summary information in a patient’s summary care record whenever C is providing local pharmaceutical services to the patient, to the extent that C, in the exercise of C’s clinical judgement, considers it appropriate to do so.
In this paragraph, a “summary care record” and “summary information” mean a summary care record and summary information within the meanings given in—
regulation 68 of the GMS Regulations (summary care records); and
regulation 61 of the PMS Regulations (summary care records).
Annotations
Textual amendments
- F1
Sch. 7 para. 13A inserted (1.4.2016) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2016 (S.I. 2016/296), regs. 1(1)(a), 5(3)
- F2
Sch. 7 para. 13A(1)(2) substituted (9.11.2020) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020 (S.I. 2020/1126), regs. 1(2), 27